Today, nearly 31% of global mortality is caused by cardiovascular disease (WHO source). Whether the source is genetic or the way of life, it is necessary to detect the problems as soon as possible, in order to be able to postpone the appearance of the diseases. Many “portable” tools, including special watches, monitor our health (fitness, physical activity, sleep, etc.) and adopt a healthy lifestyle. As soon as an abnormality is diagnosed, we can analyze the cause and try to correct it, either by a change of lifestyle, or by a drug and / or surgical treatment. Alternatively, follow up with telecardiology. Here, the goal is to continuously follow a patient who stays at home; if there is a problem with the therapy, it can be adapted. The technology also allows patients today to use their mobile phone, computer or tablet to send information (weight, heart rate, blood pressure, etc.) to health centers.
We can also mention the heart valve that is fixed almost alone when we talk about technological innovation in cardiology. This is a new kind of aortic valve. The aorta is that big artery that forms a butt, comes out of the heart to distribute the oxygenated blood to different organs. This main artery is equipped at its entrance with a valve that allows the blood expelled not to return to the heart. This new valve called “Perceval S” was put on the market in 2011 and its particularity is that it is equipped with a self-anchoring system. The surgeon can therefore replace the sick valve with this new prosthesis without sutures. It is a biological valve composed of bovine tissue, mounted on an elastic alloy structure, and which deploys, once positioned. Today, 180 patients have already benefited without problem from this technology and it is still being evaluated in 25 centers of European cardiac surgery.
The contributions of Philipp Bonhoeffer are not the least in the evolution of cardiology technology. He designed the Infundibular Reducer, a viable pulmonary implantation approach for patients. The team developed virtual implantation techniques that theoretically tested the implanted prostheses and implanted them during computer simulation in the actual anatomy of the patients reproduced compared to data acquired by CT or magnetic resonance imaging. These modern approaches have made it possible to develop the best prosthetic design and significantly reduce the need for animal testing. As a result, Medtronic has agreed to participate in the project and laboratory tests and in vivo experiments have quickly yielded satisfactory results. It has also brought innovation in the field of catheterization and has enabled affordability to care and prostheses thanks to the multi-track system. The concept of this device is to use two catheters on a single metal guide, to reduce the size of the percutaneous vascular approach and provide a very economical alternative to the Inoue system. Let us note that Philipp Bonhoeffer collaborated with Allen Tower to develop this device.